Literature DB >> 3193810

The incidence of hybrid acute leukaemias.

G J Ruiz-Argüelles1, E Lobato-Mendizábal, A Marín-López.   

Abstract

During a 4-yr period, 292 patients with acute leukaemia were studied using morphology, cytochemistry and immunologic reagents to determine the cell lineage of the leukaemia. One hundred and sixty-three cases were shown to be acute lymphoblastic leukaemia (ALL), 127 acute myeloblastic leukaemia (AML) and two cases (0.6%) were classified as hybrid acute leukaemias. One was biphenotypic in which the blast cells displayed both T-lymphoid (60% E-rosettes) and megakaryocytic markers (47% CDw41/glycoprotein IIb/IIIa antigen, 50% myeloperoxidase). The second was a bilineal acute leukaemia in which some blast cells displayed B-lymphoid (47% CD10/CALLA, 40% acid phosphatase) features and other megakaryocytic (33% coagulation factor VIII:WVf antigen)/myeloid (30% Sudan Black) features. This study suggests that hybrid acute leukaemia are rare.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3193810     DOI: 10.1016/0145-2126(88)90002-1

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

1.  Phenotypic changes in acute myeloid leukaemia: implications in the detection of minimal residual disease.

Authors:  A Macedo; J F San Miguel; M B Vidriales; M C López-Berges; M A García-Marcos; M Gonzalez; C Landolfi; A Orfão
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

2.  Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification.

Authors:  Lingzhi Yan; Nana Ping; Mingqing Zhu; Aining Sun; Yongquan Xue; Changgeng Ruan; Hans G Drexler; Roderick A F Macleod; Depei Wu; Suning Chen
Journal:  Haematologica       Date:  2012-05-11       Impact factor: 9.941

3.  Establishment and genetic characterization of a novel mixed-phenotype acute leukemia cell line with EP300-ZNF384 fusion.

Authors:  Nana Ping; Huiying Qiu; Qian Wang; Haiping Dai; Changgeng Ruan; Stefan Ehrentraut; Hans G Drexler; Roderick A F MacLeod; Suning Chen
Journal:  J Hematol Oncol       Date:  2015-08-21       Impact factor: 17.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.